Nuclear targeting of mutant huntingtin increases toxicity

Molecular and Cellular Neurosciences

Volumn 14, Issue 2, 1999, Pages 121-128

  Peters, Matthew F ^a   Nucifora Jr , Frederick C ^a   Kushi, Jonathan ^a   Seaman, Holly C ^a   Cooper, Jillian K ^a   Herring, William J ^a   Dawson, Valina L ^a   Dawson, Ted M ^a   Ross, Christopher A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CYTOPATHOGENIC EFFECT; GENETIC TRANSFECTION; HUNTINGTON CHOREA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032847708     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1999.0773     Document Type: Article

References (35)

1. Andrew S. E., Goldberg Y. P., Hayden M. R. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum. Mol. Genet. 6:1997;2005-2010.
2. Aronin N., Chase K., Young C., Sapp E., Schwarz C., Matta N., Kornreich R., Landwehrmeyer B., Bird E., Beal M. F. CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. Neuron. 15:1995;1193-1201.
3. Becher M., Kotzuk J., Sharp A., Davies S., Bates G., Price D., Ross C. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4:1998;387-397.
4. Boutell, J. M, Thomas, P, Neal, J. W, Weston, V. J, Duce, J, Harper, P. S, Jones, A. L. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin, Hum. Mol. Genet. in press.
5. Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M., Yunis W. S., Duvick L. A., Zoghbi H. Y., Orr H. T. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82:1995;937-948.
6. Cooper J. K., Schilling G., Peters M. F., Herring W. J., Sharp A. H., Kaminsky Z., Masone J., Khan F. A., Delanoy M., Borchelt D. R., Dawson V. L., Dawson T. M., Ross C. A. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7:1998;783-790.
7. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
8. De Rooij K. E., Dorsman J. C., Smoor M. A., Den Dunnen J. T., Van Ommen G. J. Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5:1996;1093-1099.
9. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J. P., Carraway R., Reeves S. A., Boyce F. M., Aronin N. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14:1995;1075-1081.
10. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
11. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., Folstein S., Ross C., Franz M., Abbott M., Young A., Penney J., Hollingsworth Z., Shoulson I., Lazzarini A., Falek A., Gomez W., Ramos M., Sanchez-Ramos J., Snodgrass S., deYoung M., Wexler N., Moscowitz C., Pehchaszadeh G., MacFarlane H., Anderson M., Jenkins B., Srinidhi J., Barnes G., Gusella J., MacDonald M. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4:1993;387-392.
12. Eberhart D. E., Malter H. E., Feng Y., Warren S. T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization an nuclear export signals. Hum. Mol. Genet. 5:1996;1083-1091.
13. Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol. Cell Biol. 5:1985;3610-3616.
14. Furtado S., Suchowersky O., Rewcastle B., Graham L., Klimek M. L., Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann. Neurol. 39:1996;132136.
15. Group THDCR. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
16. Hackam A. S., Singaraja R., Wellington C. L., Metzler M., McCutcheon K., Zhang T., Kalchman M., Hayden M. R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141:1998;1097-1105.
17. Hackam A. S., Singaraja R., Zhang T., Gan L., Hayden M. R. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hum. Mol. Genet. 8:1999;25-33.
18. Harper P. S. Huntington's Disease. 1996;Saunders, London.
19. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A., van Ommen G. J., Galjaard H. Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2:1993;2069-2073.
20. Jans D. A., Hubner H. Regulation of protein transport to the nucleus: Central role of phosphorylation. Physiol. Rev. 76:1996;651-685.
21. Kim T. W., Tanzi R. E. Neuronal intranuclear inclusions in polyglutamine diseases: Nuclear weapons or nuclear fallout? Neuron. 21:1998;657-659.
22. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., Orr H. T. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 95:1998;41-53.
23. Lunkes A., Mandel J. L. A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet. 7:1998;1355-1361.
24. Martindale D., Hackam A., Wieczorek A., Ellerby L., Wellington C., McCutcheon K., Singaraja R., Kazemi-Esfarjani P., Devon R., Kim S. U., Bredesen D. E., Tufaro F., Hayden M. R. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18:1998;150-154.
25. Matilla A., Koshy B. T., Cummings C. J., Isobe T., Orr H. T., Zoghbi H. Y. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature. 389:1997;974-978.
26. Perutz M. F., Johnson T., Suzuki M., Finch J. T. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 91:1994;5355-9358.
27. Ross C. A. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 19:1997;1147-1150.
28. Saudou F., Finkbeiner S., Devys D., Greenberg M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
29. Sharp A. H., Loev S. J., Schilling G., Li S. H., Li X. J., Bao J., Wagster M. V., Kotzuk J. A., Steiner J. P., Lo A., Hedreen J., Sisodia S., Snyder S. H., Dawson T. M., Ryugo D. K., Ross C. A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14:1995;1065-1074.
30. Skinner P. J., Koshy B. T., Cummings C. J., Klement I. A., Helin K., Servadio A., Zoghbi H. Y., Orr H. T. Ataxin-1 with an expanded glutamine tract alters nuclear matrix- associated structures. Nature. 389:1997;971-974.
31. Stine O. C., Pleasant N., Franz M. L., Abbott M. H., Folstein S. E., Ross C. A. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2:1993;1547-1549.
32. Stott K., Blackburn J. M., Butler P. J. G., Pertutz M. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 92:1995;6509-6513.
33. Tait D., Riccio M., Sittler A., Scherzinger E., Santi S., Ognibene A., Maraldi N. M., Lehrach H., Wanker E. E. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet. 7:1998;991-997.
34. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E. C., Mandel J. L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10:1995a;104-110.
35. Trottier Y., Lutz Y., Stevanin G., Imbert G., Devys D., Cancel G., Saudou F., Weber C., David G., Tora L., Agid Y., Brice A., Mandel J.-L. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 378:1995b;403-406.